AlphaMadera's AlphaVal page computes Snap-on Incorporated's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag SNA as undervalued, fairly valued, or overvalued.

What is Snap-on Incorporated's fair value?

Fair value for SNA is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value SNA?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from SNA's most recent reported fundamentals.

SNA - Snap-on Incorporated

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $415.33 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 65% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Moderate

Trading 24.8% above fair value

Current Price $404.62

Bear Case $259.44 35.9% downside ($259.44 - $404.62) / $404.62 = -35.9% $19.60 × 12x P/E

Fair Value $324.31 19.8% downside ($324.31 - $404.62) / $404.62 = -19.8% $19.60 × 15x P/E

Bull Case $389.17 3.8% downside ($389.17 - $404.62) / $404.62 = -3.8% $19.60 × 18x P/E

Adjust Assumptions

P/E Multiple

15.0x

Adjusted EPS

19.6$

Key Value Driver

Normalized P/E multiple (15x base case)

Implied Market Multiple 20.6x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $415.33 from 17 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $324.31 per share.

Warnings

ℹ Wall Street's average price target is $415.33 (from 17 analysts). Our estimate is 29% below the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples